Peak6 Investments LLC Bristol Myers Squibb CO Put Options Transaction History

Peak6 Investments LLC

$37.5 Billion
Q2 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $8.3 Million - $10.9 Million	206,100 Added 2061.0%	216,100 $8.97 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $1.27 Million - $1.44 Million	-26,400 Reduced 72.53%	10,000 $542,000
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $552,672 - $659,490	11,400 Added 45.6%	36,400 $1.87 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $6.23 Million - $6.97 Million	-107,700 Reduced 81.16%	25,000 $1.45 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $5.7 Million - $6.33 Million	89,500 Added 207.18%	132,700 $8.49 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $21.2 Million - $24 Million	-322,300 Reduced 88.18%	43,200 $2.99 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $5.69 Million - $6.74 Million	83,100 Added 29.43%	365,500 $26.3 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $62,842 - $37.1 Million	-483,400 Reduced 63.12%	282,400 $20.1 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $12 Million - $13.2 Million	165,500 Added 27.57%	765,800 $59 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $21.7 Million - $26.1 Million	-353,400 Reduced 37.06%	600,300 $43.8 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $32.1 Million - $37.5 Million	599,400 Added 169.18%	953,700 $59.5 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $603,534 - $706,962	-10,200 Reduced 2.8%	354,300 $21 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $6.28 Million - $6.84 Million	-101,500 Reduced 21.78%	364,500 $24.4 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $16.9 Million - $19 Million	-284,400 Reduced 37.9%	466,000 $29.4 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $2.96 Million - $3.35 Million	51,200 Added 7.32%	750,400 $46.5 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $15.2 Million - $16.9 Million	265,400 Added 61.18%	699,200 $42.2 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $63.4 Million - $74.2 Million	-1,157,400 Reduced 72.74%	433,800 $25.5 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $12.9 Million - $18.8 Million	278,500 Added 21.22%	1,591,200 $88.7 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $41.5 Million - $54.2 Million	843,700 Added 179.89%	1,312,700 $84.3 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $919,555 - $1.09 Million	-21,500 Reduced 4.38%	469,000 $23.6 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $3.86 Million - $4.27 Million	86,600 Added 21.44%	490,500 $22.2 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $1.42 Million - $1.69 Million	-31,400 Reduced 7.21%	403,900 $19.3 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $5.25 Million - $6.81 Million	107,700 Added 32.88%	435,300 $22.6 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $18.1 Million - $20.4 Million	327,600 New	327,600 $20.3 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.5 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.08 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.66 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.8 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.01 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account